403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Doseology Sciences Inc
(MENAFN- Baystreet) 01:41 PM EST - Doseology Sciences Inc : Announces the appointment of Patrick W. Sills as Strategic Go-to-Market Advisor. Mr. Sills is an experienced commercial strategist with over 15 years of leadership in the nicotine and functional CPG sectors. His career includes senior roles with Philip Morris International and Fontem Ventures B.V., where he led initiatives in go-to-market strategy, product commercialization, and regulatory compliance within the nicotine pouch and reduced-risk product categories. Mr. Sills will support Doseology's commercialization strategy, focusing on product positioning, distribution, regulatory considerations, and market expansion opportunities within the Company's oral stimulant portfolio. Doseology Sciences Inc
shares C are trading up one cent at $1.50.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment